No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial - Reply by Rogers et al.

British Journal of Nutrition

Volumn 100, Issue 6, 2008, Pages 1349-1351

  Rogers, Peter J ^a   Appleton, Katherine M ^b   Kessler, David ^a   Peters, Tim J ^a   Gunnell, David ^a   Hayward, Robert C ^a   Heatherley, Susan V ^a   Christian, Leonie M ^a   McNaughton, Sarah A ^c   Ness, Andy R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DRUG CHOICE; EVIDENCE BASED MEDICINE; FAT INTAKE; FATTY ACID OXIDATION; HUMAN; MONOTHERAPY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

EID: 56349114957     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508975656     Document Type: Note

References (26)

1. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA & Ness AR (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial. Br J Nutr 99, 421-431.
2. Richardson AJ (2008) n-3 Fatty acids and mood: The devil is in the detail. Br J Nutr 99, 221-223.
3. Appleton KM, Rogers PJ & Ness AR (2008) Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? Nutr Res Rev 21, (In the Press).
4. Hooper L, Thompson RL, Harrison RA, et al. (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: Systematic review. BMJ 332, 752-755.
5. Hibbeln JR & Salem N (1995) Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J Clin Nutr 62, 1-9.
6. Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl., 560S-569S.
7. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK & Marangell LB (1999) Omega-3 fatty acids in bipolar disorder - a preliminary double-blind, placebo- controlled trial. Arch Gen Psychiatry 56, 407-412.
8. Scientific Advisory Committee on Nutrition & Committee on Toxicity (2004) Advice on Fish Consumption: Benefits and Risks. London: The Stationery Office.
9. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Seung Kim HF & Puryear LJ (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996-998.
10. Silvers KM, Woolley CC, Hamilton FC, Watts PM & Watson RA (2005) Randomized double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211-218.
11. Grenyer BFS, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P & Howe PRC (2007) Fish oil supplementation in the treatment of major depression: A randomised doubleblind placebo-controlled trial. Prog Neuropharmacol Biol Psychiatry 31, 1393-1396.
12. Su KP, Huang SY, Chiu CC & Shen WW (2003) Omega-3 fatty acids in major depressive disorder - a preliminary double-blind placebo-controlled trial. Eur Neuropsychopharmacol 13, 267-271.
13. Nemets H, Nemets B, Apter A, Bracha Z & Belmaker RH (2006) Omega-3 treatment of children's depression: A controlled, double-blind pilot study. Am J Psychiatry 163, 1098-1100.
14. Nemets B, Stahl Z & Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477-479.
15. Peet MB & Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913-919.
16. Frangou S, Lewis M & McCrone P (2006) Efficacy of ethyleicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled study. Br J Psychiatry 188, 46-50.
17. Keck PE Jr, Mintz J, McElroy SL, et al. (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60, 1020-1022.
18. Hibbeln JR, Nieminen LRG, Blasbalg TL, Riggs JA & Lands WEM (2006) Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 83, Suppl. 6, 1483S-1493S.
19. Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM & Renshaw PF (2004) Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry 161, 1922-1924.
20. Chalon S, Delion-Vancassel S, Blezung C, Guilloteau D, Leguisquet AM, Besnard JC & Durand G (1998) Dietary fish oil affects monoaminergic neurotransmission and behaviour in rats. J Nutr 128, 2512-2519.
21. Rogers PJ (2001) A healthy body, a healthy mind: Long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60, 135-143.
22. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D & Ness AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J Clin Nutr 84, 1308-1316.
23. Zhang J & Li Y (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial - comments by Zhang and Li. Br J Nutr doi:10.1017/S0007114508975644.
24. Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M & Campbell H (2007) Dietary fatty acids and colorectal cancer: A case-control study. Am J Epidemiol 166, 181-195.
25. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ & Johnson BT (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5 260-267.
26. Owen AJ, Batterham MJ, Probst YC, Grenyer BFS & Tapsell LC (2005) Low vitamin E levels in major depression: Diet or disease? Eur J Clin Nutr 59, 304-306.